Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for more than 20 years, according to U.S. News & World Report’s annual survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $425 million awarded in 2019.
Penn Med is home to some of the world’s leading clinicians and researchers in nearly every area of medicine. Our renowned physicians offer patients access to cutting-edge treatments and personalize their care using our unique Electronic Health Record system—one that connects all aspects of a patient’s care at Penn Medicine so doctors can share information and make better decisions about treatment options. This gives our patients continuity throughout their experience at Penn Med—whether they are being seen at our hospitals or one our many outpatient facilities located across Pennsylvania and New Jersey.
We are also committed to training future leaders in medicine through our residency programs as well as our MD/PhD program—the largest fully integrated program in biomedical sciences in the country that trains tomorrow’s physician-scientists who will make discoveries that transform lives worldwide.
In addition to its educational programs, Penn Medicine is also a leader in biomedical research with ongoing studies into groundbreaking new treatments for diseases such as cancer, heart disease, Alzheimer’s disease, diabetes, and many others. Our researchers receive millions each year in grant funding from federal agencies like NIH as well as private foundations to support their work investigating everything from basic science questions about how cells work to clinical trials testing new therapies on patients.
This commitment to innovation doesn’t stop when a new therapy or diagnostic tool is developed—we also have an industry-leading commercialization program that works with inventors within Penn Medicine to help bring their discoveries out into society where they can improve health for people around the world